Ads
related to: als clinical trials 2013
Search results
Results from the WOW.Com Content Network
Rasheda Ali on National and Local News: BrainStorm's ALS Clinical Trial Results Exceeded Expectations NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)-- BrainStorm Cell Therapeutics (OTCQB: BCLI ...
The institute has raised and spent more than $100 million on research into effective treatments for ALS and practices open-source science. [19] After the discovery that the multiple sclerosis drug Gilenya might also be a treatment for ALS, the Institute enrolled 30 people in a Phase 2A clinical trial the drug in 2013, though it did not progress further.
Repetitive transcranial magnetic stimulation had been studied in amyotrophic lateral sclerosis in small and poorly designed clinical trials; as of 2013, there was insufficient evidence to know whether rTMS is safe or effective for ALS. [13]
BrainStorm Launches US Activities for Its Multi-Center ALS Clinical Trial NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)-- BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of ...
The drug was initially investigated in ALS by Knopp Biosciences and Biogen Idec. A 2010 Phase II clinical trial showed a slowing of ALS disease progression and mortality benefits. [8] In January 2013, Biogen Idec discontinued its development of dexpramipexole in ALS due to lack of efficacy in the Phase III study. [9]
BrainStorm's Outstanding ALS Clinical Data Chosen to Kick-Off the Israel Neurological Association Meeting NEW YORK & PETACH TIKVA, Israel--(BUSINESS WIRE)-- BrainStorm Cell Therapeutics (OTC.QB ...
The first genome-wide association study (GWAS) of ALS was published in 2007, and 14 GWASs total had been published through 2013. They have contributed significantly to our understanding of ALS genetics; for example, a 2010 GWAS studying ALS in Finland led to discovery of the role of mutations at the C9orf72 locus in ALS.
(Reuters) -Drug developer Denali Therapeutics said on Friday its and partner Sanofi's experimental drug for a fatal neurodegenerative disease failed to slow decline of motor function in a mid ...
Ads
related to: als clinical trials 2013